Despite its immune stimulatory potential, inflammation has also been shown to modify the tumor microenvironment by promoting immunosuppressive pathways, such as PD-L1 expression or MHC down-regulation through cytokine secretion. The gene discussed is HLA-C; the disease is neoplasm.